TrialsgrambetaRCTs are beautiful

Herbrecht (voriconazole)

2002

Voriconazole versus Amphotericin B for Invasive Aspergillosis

In 277 patients with definite or probable invasive aspergillosis, voriconazole improved successful response and 12-week survival compared with amphotericin B deoxycholate.

Result

Successful response at 12 weeks
Absolute difference
21.2 points

The absolute difference is derived from the event rates.

Also reported: 12-week survival 70.8 % vs 57.9 %.

Original publication
Subtopic
Invasive aspergillosis
Design
Open-label RCT
Relevance
Important: one of several pillars.
Source
Herbrecht R, et al. N Engl J Med. 2002;347(6):408-415.doi 10.1056/NEJMoa020191

Discussion & critique

Established voriconazole as first-line therapy for invasive aspergillosis. Isavuconazole later proved a tolerability-equivalent alternative.